REGISTER
A World First: After a Pig Kidney, He Received a Human Kidney
Experts predict that in the future, patients with kidney failure may undergo both pig-kidney transplantation and human-kidney transplantation over the course of their lives.

A year ago, 66-year-old American patient Tim Andrews underwent a pig-kidney transplant because of end-stage renal failure.

Now Tim has created another great miracle in medical history: after the pig kidney was removed, he received a human kidney and has been given a new lease on life.

“I am the only person in the world who first had a pig kidney and then a human kidney. No one has ever tried anything like this before. It is really cool!” Tim said in an interview with CNN in mid-January.

Record survival with a pig kidney in a human

For decades, the ultimate goal of xenotransplantation has been to use mass-producible pig organs to replace scarce human organs and sustain patients’ lives.

For Tim, the choice was not a difficult one. He had long-standing diabetes and advanced kidney disease and needed hours of dialysis three days a week.

Under ordinary circumstances, Tim’s preferred treatment would have been a human kidney transplant. The average waiting time for a donor kidney is three to five years, but because Tim has type O blood, his estimated wait would have stretched to nearly 10 years.

On February 7, 2025, with no other option left, Tim underwent pig-kidney transplantation at Massachusetts General Hospital in the United States. He was discharged just one week later and no longer needed dialysis.

But because of rejection, after a record 271 days of coexistence with the pig kidney, doctors had to remove it, and Tim resumed dialysis.

“I cried then,” Tim told CNN. On the day the pig kidney was removed, he told his family in despair that he did not think he would live another year.

But at midnight on January 12 this year, doctors at Massachusetts General Hospital urgently contacted Tim, saying they had just found a human kidney that was almost a perfect match and telling him to come to the hospital immediately for transplant surgery at 8 a.m. the next day.

The operation, which began on the morning of the 13th, lasted three hours and was highly successful. Just three days later, Tim was discharged. He is now recuperating at home and preparing for a new life.

First a pig organ, then a human organ

According to available statistics, about 2 million people worldwide need organ transplants each year, yet fewer than 10% of transplant needs are met. In China, about 300,000 patients with end-stage organ failure need transplants each year, but the organ supply-to-demand ratio is only 1:30.

To change this situation, over the past 20 years scientists have carried out a series of modifications in pigs, including eliminating porcine endogenous viruses to ensure cross-species biosafety, editing genes to improve compatibility with the human body, and conducting hundreds of exploratory animal experiments.

It was not until January 2022 that pig-organ transplantation reached a milestone. David Bennett, a 57-year-old American, received the world’s first pig heart transplant, marking the formal entry of large pig-organ transplantation into human application. Tim, meanwhile, set the world record for the longest coexistence between a human and a pig organ.

But during Tim’s 271 days with the pig kidney, he had to take large amounts of medication every day to maintain a balance between the organ and his immune system. During that period, he also suffered two severe infections because the anti-rejection drugs suppressed his immunity.

In the end, the pig kidney was still removed after functional failure. Prof. Tongyu Zhu, director of the Shanghai Key Laboratory of Organ Transplantation, said this outcome was predictable.

“Even in human-to-human transplantation, different types of rejection can still occur. The genetic differences between pigs and humans are even greater, and their chromosome numbers are different, so this problem is still far from being fully solved,” Prof. Zhu told MedJ.

Prof. Gang Chen, deputy director of the Institute of Organ Transplantation at Tongji Hospital in Wuhan and also a researcher in pig-organ transplantation, said that gene editing can knock out several major pig antigens, but unknown antigens may still trigger new rejection reactions. Long-term coexistence of pig organs in the human body still requires deeper study.

Despite these many challenges, Tim’s experience has already created a new medical possibility: using pig-organ transplantation as a “bridging strategy” to help patients through a dangerous period and buy time until a healthy human organ becomes available.

Likely to reach the clinic within five years

For Tim, receiving a pig kidney meant not only hope of escaping dialysis but also a new dawn for the much larger population of patients with end-stage kidney disease.

“While waiting for a donor kidney match, in some cases a pig-kidney transplant is much better than dialysis at maintaining bodily function,” said Leonardo Riella, Tim’s attending physician and medical director of kidney transplantation at Massachusetts General Hospital.

In fact, after Tim underwent xenotransplantation in 2025, he said he immediately felt “renewed”: “My mind became clearer. I no longer had that common post-dialysis fogginess. I rarely felt tired anymore and suddenly had much more energy.”

After Tim’s pig kidney was removed, however, Leonardo said that although dialysis could still keep him alive, his physical condition declined markedly, his muscle mass fell, and he became fatigued. “That is because dialysis cannot fully replace all the functions of a healthy kidney.”

Therefore, without the pig-kidney transplant, it is hard to say whether Tim would have been strong enough to wait for this human kidney.

The help of the pig kidney allowed Tim to recover enough strength.

Worth noting is that the same treatment concept may be applied to more fields of organ transplantation. In China, in 2024, Xijing Hospital of the Air Force Medical University announced the world’s first successful heterotopic transplantation of a whole pig liver into a brain-dead patient.

Prof. Dengke Pan, founder of Chengdu Clonorgan Biotechnology and inventor of China’s first medical transplant pig, told MedJ: “Pig-liver transplantation is technically difficult, but it may serve as a short-term heterotopic auxiliary liver to help patients with acute liver failure through a dangerous period. That period may be a week or a month, and once the patient’s own liver function recovers, the heterotopic pig liver can then be removed.”

“Based on previous studies, it is entirely feasible for a pig liver to assume part of physiological function in the short term. My team and I are also preparing to advance clinical research in this direction,” Prof. Pan said.

It is understood that global pig-organ transplantation research has now entered an explosive phase. In the United States, two teams have announced formal regulatory approval to launch clinical trials of pig-kidney transplantation. Since 2024, Chinese scientific teams have also successively carried out transplantation studies involving pig kidneys, pig livers, and pig lungs in patients or brain-dead human bodies.

Prof. Robert Montgomery, director of the NYU Langone Transplant Institute and leader of the world’s first clinical trial of pig-organ transplantation, believes that in the future patients with kidney failure will experience both xenotransplantation and allotransplantation over the course of their lives.

“As technology advances and xenogeneic organs survive longer and longer, pig-organ transplantation will become a feasible clinical treatment option for patients within the next five years,” he said.

0
0
Loading